{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-105953","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2026-09-08T21:12:57+00:00","discovered_at":"2026-09-08T21:14:00.277667+00:00","generated_at":"2026-09-08T21:14:19.706704+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"United Therapeutics enters $477.6M ASR to complete $2B buyback authorization","bullets":["Entered ASR with Citibank to repurchase ~$477.6M stock; upfront payment ~Sept 10, 2026.","Initial delivery ~719,376 shares (75% of anticipated total based on 9/8/26 close); final settlement Q4 2026.","Prior repurchases: $1.5B ASR in March 2026 and $22.4M open-market in Q3 2026.","CEO states $4B returned to shareholders in ~2.5 years; ~42.9M shares outstanding as of Sept 4, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-105953","json":"https://secwatch.observer/filing/0001104659-26-105953.json","markdown":"https://secwatch.observer/filing/0001104659-26-105953.md","text":"https://secwatch.observer/filing/0001104659-26-105953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926105953/0001104659-26-105953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465926105953/tm2624887d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-08T21:14:19.706704+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}